
Privilège Ventures
Europe, Ticino, Switzerland, Lugano
Description
Swiss-based Venture Capital firm authorised by FINMA investing in seed stage companies
Investor Profile
Privilège Ventures has backed more than 18 startups, with 0 new investments in the last 12 months alone. The firm has led 8 rounds, about 44% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Series A, Pre Seed rounds (top funding stages).
- Majority of deals are located in Switzerland, Italy, France.
- Strong thematic focus on Health Care, Software, Wearables.
Stage Focus
- Seed (67%)
- Series A (11%)
- Pre Seed (11%)
- Series Unknown (11%)
Country Focus
- Switzerland (83%)
- Italy (6%)
- France (6%)
Industry Focus
- Health Care
- Software
- Wearables
- Biotechnology
- Hardware
- Robotics
- Wellness
- Health Diagnostics
- Medical Device
- Industrial Automation
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.